FDA Approves Unknown Drug — TP ANDA HOLDINGS

# FDA Approves ANDA Application for TP ANDA Holdings TP ANDA Holdings received FDA approval for ANDA219509 on June 23, 2025, potentially strengthening its position in the generic pharmaceutical market and enabling the company to expand its product portfolio. The approval may provide the manufacturer with additional revenue opportunities and competitive advantage in a growing segment of the generic drug industry.